Pfizer to Start Pilot Delivery Program for Its COVID-19 Vaccine in Four U.S. States

Reuters has learned Pfizer is piloting a delivery system for its experimental COVID-19 vaccine in four states, as the drugmaker focuses on distribution hurdles related to the vaccine's ultra-cold storage requirements. The vaccine must be transported and stored at -94 degrees F, significantly below the standard for vaccines of 36-46 degrees F. Pfizer said, "We are hopeful that results from this vaccine delivery pilot will serve as the model for other U.S. states and international governments, as they prepare to implement effective COVID-19 vaccine programs." The company selected Rhode Island, Texas, New Mexico, and Tennessee for the pilot after examining such factors as size, diversity of populations, immunization infrastructure, and individuals residing in varied urban and rural settings.